All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

68 Ga-labelled desferrioxamine-B for bacterial infection imaging

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F21%3A00540695" target="_blank" >RIV/61388971:_____/21:00540695 - isvavai.cz</a>

  • Alternative codes found

    RIV/00098892:_____/21:N0000089

  • Result on the web

    <a href="https://link.springer.com/article/10.1007%2Fs00259-020-04948-y" target="_blank" >https://link.springer.com/article/10.1007%2Fs00259-020-04948-y</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s00259-020-04948-y" target="_blank" >10.1007/s00259-020-04948-y</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    68 Ga-labelled desferrioxamine-B for bacterial infection imaging

  • Original language description

    Purpose With the increase of especially hospital-acquired infections, timely and accurate diagnosis of bacterial infections is crucial for effective patient care. Molecular imaging has the potential for specific and sensitive detection of infections. Siderophores are iron-specific chelators recognized by specific bacterial transporters, representing one of few fundamental differences between bacterial and mammalian cells. Replacing iron by gallium-68 without loss of bioactivity is possible allowing molecular imaging by positron emission tomography (PET). Here, we report on the preclinical evaluation of the clinically used siderophore, desferrioxamine-B (Desferal (R), DFO-B), radiolabelled with(68)Ga for imaging of bacterial infections. Methods In vitro characterization of [Ga-68]Ga-DFO-B included partition coefficient, protein binding and stability determination. Specific uptake of [Ga-68]Ga-DFO-B was tested in vitro in different microbial cultures. In vivo biodistribution was studied in healthy mice and dosimetric estimation for human setting performed. PET/CT imaging was carried out in animal infection models, representing the most common pathogens. Results DFO-B was labelled with(68)Ga with high radiochemical purity and displayed hydrophilic properties, low protein binding and high stability in human serum and PBS. The high in vitro uptake of [Ga-68]Ga-DFO-B in selected strains ofPseudomonas aeruginosa,Staphylococcus aureusandStreptococcus agalactiaecould be blocked with an excess of iron-DFO-B. [Ga-68]Ga-DFO-B showed rapid renal excretion and minimal retention in blood and other organs in healthy mice. Estimated human absorbed dose was 0.02 mSv/MBq. PET/CT images of animal infection models displayed high and specific accumulation of [Ga-68]Ga-DFO-B in bothP. aeruginosaandS. aureusinfections with excellent image contrast. No uptake was found in sterile inflammation, heat-inactivatedP. aeruginosaorS. aureusandEscherichia colilacking DFO-B transporters. Conclusion DFO-B can be easily radiolabelled with(68)Ga and displayed suitable in vitro characteristics and excellent pharmacokinetics in mice. The high and specific uptake of [Ga-68]Ga-DFO-B byP. aeruginosaandS. aureuswas confirmed both in vitro and in vivo, proving the potential of [Ga-68]Ga-DFO-B for specific imaging of bacterial infections. As DFO-B is used in clinic for many years and the estimated radiation dose is lower than for other(68)Ga-labelled radiopharmaceuticals, we believe that [Ga-68]Ga-DFO-B has a great potential for clinical translation.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10606 - Microbiology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    European Journal of Nuclear Medicine and Molecular Imaging

  • ISSN

    1619-7070

  • e-ISSN

  • Volume of the periodical

    48

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    13

  • Pages from-to

    372-382

  • UT code for WoS article

    000558776500002

  • EID of the result in the Scopus database

    2-s2.0-85088837064